Skip to main content

Advertisement

SpringerLink
Log in

Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus

  • ORIGINAL ARTICLE
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The objective is to perform a multimodal ophthalmological evaluation, including optical coherence angiography (OCTA), asymptomatic APS secondary to SLE (APS/SLE), and compare to SLE patients and control group (CG). We performed a complete structural/functional ophthalmological evaluation using OCTA/microperimetry exam in all participants. One hundred fifty eyes/75 asymptomatic subjects [APS/SLE (n = 25), SLE (n = 25), and CG (n = 25)] were included. Ophthalmologic abnormalities occurred in 9 (36%) APS/SLE, 11 (44%) SLE, and none of CG (p < 0.001). The most common retinal finding was Drusen-like deposits (DLDs) exclusively in APS/SLE and SLE (16% vs. 24%, p = 0.75) whereas severe changes occurred solely in APS/SLE [2 paracentral acute middle maculopathy (PAMM) and 1 homonymous quadrantanopsia]. A trend of higher frequency of antiphospholipid antibody (aPL) triple positivity (100% vs. 16%, p = 0.05) and higher mean values of adjusted Global Antiphospholipid Syndrome Score (aGAPSS) (14 ± 0 vs. 9.69 ± 3.44, p = 0.09) was observed in APS/SLE with PAMM vs. those without this complication. We identified that ophthalmologic retinal abnormalities occurred in more than 1/4 of asymptomatic APS/SLE and SLE. DLDs are the most frequent with similar frequencies in both conditions whereas PAMM occurred exclusively in APS/SLE patients. The possible association of the latter condition with aPL triple positivity and high aGAPSS suggests these two conditions may underlie the retinal maculopathy. Our findings in asymptomatic patients reinforce the need for early surveillance in these patients.

Key Points

• Retinal abnormalities occur in more than 1/4 of asymptomatic APS/SLE and SLE patients.

• The occurrence of PAMM is possibly associated with APS and DLDs with SLE.

• Presence of aPL triple positivity and high aGAPSS seem to be risk factors for PAMM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

Data will be made available under request when appropriate and after publication of the corresponding manuscripts.

References

  1. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306. https://doi.org/10.1111/j.1538-7836.2006.01753.x

    Article  CAS  PubMed  Google Scholar 

  2. Vianna JL, Khamashta MA, Ordi-Ros J et al (1994) Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 96:3–9. https://doi.org/10.1016/0002-9343(94)90108-2

    Article  CAS  PubMed  Google Scholar 

  3. Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346:752–763. https://doi.org/10.1056/NEJMra002974

    Article  CAS  PubMed  Google Scholar 

  4. Belizna C, Stojanovich L, Cohen-Tervaert JW, Fassot C, Henrion D, Loufrani L et al (2018) Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: are they different entities? Autoimmun Rev 17(8):739–745. https://doi.org/10.1016/j.autrev.2018.01.027

    Article  PubMed  Google Scholar 

  5. de Franco AM, Medina FMC, Balbi GGM, Levy RA, Signorelli F (2020) Ophthalmologic manifestations in primary antiphospholipid syndrome patients: a cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature. Lupus 29(12):1528–1543. https://doi.org/10.1177/0961203320949667

    Article  PubMed  Google Scholar 

  6. Cobo-Soriano R, Sánchez-Ramón S, Aparicio MJ, Teijeiro MA, Vidal P, Suárez-Leoz M et al (1999) Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol 128(6):725–732. https://doi.org/10.1016/s0002-9394(99)00311-6

    Article  CAS  PubMed  Google Scholar 

  7. Trese MGJ, Thanos A, Yonekawa Y, Randhawa S (2017) Optical coherence tomography angiography of paracentral acute middle maculopathy associated with primary antiphospholipid syndrome. Ophthalmic Surg Lasers Imaging Retina 48(2):175–178. https://doi.org/10.3928/23258160-20170130-13

    Article  PubMed  Google Scholar 

  8. Sarraf D, Rahimy E, Fawzi AA et al (2013) Paracentral acute middle maculopathy: a new variant of acute macular neuroretinopathy associated with retinal capillary ischemia. JAMA Ophthalmol 131(10):1275–1287. https://doi.org/10.1001/jamaophthalmol.2013.4056

    Article  PubMed  Google Scholar 

  9. Silpa-archa S, Lee JJ, Foster CS (2016) Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol 100:135–141. https://doi.org/10.1136/bjophthalmol-2015-306629

    Article  PubMed  Google Scholar 

  10. Shoughy SS, Tabbara KF (2016) Ocular findings in systemic lupus erythematosus. Saudi J Ophthalmol 30(2):117–121. https://doi.org/10.1016/j.sjopt.2016.02.001

    Article  PubMed  PubMed Central  Google Scholar 

  11. - Pelegrín L, Morató M, Araújo O, Figueras-Roca M, Zarranz-Ventura J, Adán A et al (2022) Preclinical ocular changes in systemic lupus erythematosus patients by optical coherence tomography. Rheumatology keac626. https://doi.org/10.1093/rheumatology/keac626

  12. Arfeen SA, Bahgat N, Adel N, Eissa M, Khafagy MM (2020) Assessment of superficial and deep retinal vessel density in systemic lupus erythematosus patients using optical coherence tomography angiography. Graefe’s Arch Clin Exp Ophthalmol 258:1261–1268. https://doi.org/10.1007/s00417-020-04626-7

    Article  Google Scholar 

  13. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https://doi.org/10.1002/art.1780400928

    Article  CAS  PubMed  Google Scholar 

  14. Gladman DD, Ibañez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288

    PubMed  Google Scholar 

  15. Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369. https://doi.org/10.1002/art.1780390303

    Article  CAS  PubMed  Google Scholar 

  16. Amigo M-C, Goycochea-Robles MV, Espinosa-Cuervo G, Medina G, Barragán-Garfias JA, Vargas A et al (2015) Development and initial validation of a damage index (DIAPS) in patients with thrombotic antiphospholipid syndrome (APS). Lupus 24(9):927–934. https://doi.org/10.1177/09612033155768

    Article  PubMed  Google Scholar 

  17. Chylack LT, Wolfe JK, Singer DM et al (1993) The lens opacities classification system III. Arch Ophthalmol 111(6):831–836. https://doi.org/10.1001/archopht.1993.01090060119035

    Article  PubMed  Google Scholar 

  18. Voleti VB, Hubschman J-P (2013) Age-related eye disease. Maturitas 75(1):29–33. https://doi.org/10.1016/j.maturitas.2013.01.018

    Article  PubMed  Google Scholar 

  19. Klinkhoff AV, Beattie CW, Chalmers A (1986) Retinopathy in systemic lupus erythematosus: relationship to disease activity. Arthritis Rheum 29(9):1152–1156. https://doi.org/10.1002/art.1780290914

    Article  CAS  PubMed  Google Scholar 

  20. Marmor MF, Kellner U, Lai TYY, Melles RB, Mieler WF (2016) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). Ophthalmol 123(6):1386–1394. https://doi.org/10.1016/j.ophtha.2016.01.058

    Article  Google Scholar 

  21. Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G (2018) Optical coherence tomography angiography. Prog Retin Eye Res 64:1–55. https://doi.org/10.1016/j.preteyeres.2017.11.003

    Article  PubMed  Google Scholar 

  22. Read RW (2004) Clinical mini-review: systemic lupus erythematosus and the eye. Ocul Immunol Inflamm 12:87–99. https://doi.org/10.1080/09273940490895308

    Article  PubMed  Google Scholar 

  23. Alderaan K, Sekicki V, Magder LS, Petri M (2015) Risk factors for cataracts in systemic lupus erythematosus (SLE). Rheumatol Int 35(4):701–708. https://doi.org/10.1007/s00296-014-3129-5

    Article  CAS  PubMed  Google Scholar 

  24. Dias-Santos A, Proenca RP, Tavares Ferreira J et al (2018) The role of ophthalmic imaging in central nervous system degeneration in systemic lupus erythematosus. Autoimmun Rev 17:617–624. https://doi.org/10.1016/j.autrev.2018.01.011

    Article  PubMed  Google Scholar 

  25. Gold D, Morris D, Henkind P (1972) Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 56(11):800. https://doi.org/10.1136/bjo.56.11.800

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Utz VM, Tang J (2011) Ocular manifestations of the antiphospholipid syndrome. Br J Ophthalmol 95:454–459. https://doi.org/10.1136/bjo.2010.182857

    Article  PubMed  Google Scholar 

  27. Zhu W, Wu Y, Xu M et al (2016) Correction: antiphospholipid antibody and risk of retinal vein occlusion: a systematic review and meta-analysis. PLoS One 11:0157536. https://doi.org/10.1371/journal.pone.0157536

    Article  CAS  Google Scholar 

  28. Lally DR, Baumal C (2014) Subretinal drusenoid deposits associated with complement- mediated IgA nephropathy. JAMA Ophthalmol 132(6):775–777. https://doi.org/10.1001/jamaophthalmol.2014.387

    Article  PubMed  Google Scholar 

  29. D’souza Y, Short CD, McLeod D, Bonshek RE (2008) Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis. Br J Ophthalmol 92(7):950–953. https://doi.org/10.1136/bjo.2007.130138

    Article  PubMed  Google Scholar 

  30. Invernizzi A, dell’Arti L, Leone G, Galimberti D, Garoli E, Moroni G, Santaniello A, Agarwal A, Viola F (2017) Drusen-like deposits in young adults diagnosed with systemic lupus erythematosus. Am J Ophthalmol 175:68–76. https://doi.org/10.1016/j.ajo.2016.11.014

    Article  CAS  PubMed  Google Scholar 

  31. Mullins RF, Aptsiauri N, Hageman GS (2001) Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye 15:390–395. https://doi.org/10.1038/eye.2001.142

    Article  CAS  PubMed  Google Scholar 

  32. Dalvin LA, Fervenza FC, Sethi S, Pulido JS (2016) Shedding light on fundus drusen associated with membranoproliferative glomerulonephritis: breaking stereotypes of types I, II, and III. Retin Cases Brief Rep 10(1):72–78. https://doi.org/10.1097/ICB.0000000000000164

    Article  PubMed  Google Scholar 

  33. Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB (2019) Pachychoroid Disease Eye 33(1):14–33. https://doi.org/10.1038/s41433-018-0158-4

    Article  PubMed  Google Scholar 

  34. Goodwin D (2014) Homonymous hemianopia: challenges and solutions. Clin Ophthalmol 8:1919–1927. https://doi.org/10.2147/OPTH.S59452

    Article  PubMed  PubMed Central  Google Scholar 

  35. Yang HK, Moon KW, Ji MJ, Han SB, Hwang JM (2018) Primary antiphospholipid syndrome presenting with homonymous quadrantanopsia. Am J Ophthalmol Case Reports 10:208–210. https://doi.org/10.1016/j.ajoc.2018.03.001

    Article  Google Scholar 

  36. Scharf J, Freund KB, Sadda S, Sarraf D (2021) Paracentral acute middle maculopathy and the organization of the retinal capillary plexuses. Prog Retin Eye Res 81:100884. https://doi.org/10.1016/j.preteyeres.2020.100884

    Article  PubMed  Google Scholar 

  37. Nakamura M, Katagiri S, Hayashi T et al (2019) Longitudinal follow-up of two patients with isolated paracentral acute middle maculopathy. Int Med Case Rep J 12:143–149. https://doi.org/10.2147/IMCRJ.S196047

    Article  PubMed  PubMed Central  Google Scholar 

  38. Moura-Coelho N, Gaspar T, Ferreira JT, Dutra-Medeiros M, Cunha JP (2020) Paracentral acute middle maculopathy-review of the literature. Graefes Arch Clin Exp Ophthalmol 258(12):2583–2596. https://doi.org/10.1007/s00417-020-04826-1

    Article  PubMed  Google Scholar 

  39. Scarinci F, Varano M, Parravano M (2019) Retinal sensitivity loss correlates with deep capillary plexus impairment in diabetic macular ischemia. J Ophthalmol 2019:7589841. https://doi.org/10.1155/2019/7589841

    Article  PubMed  PubMed Central  Google Scholar 

  40. Neto TS, Neto ED, Balbi GG, Signorelli F, Higashi AH, Monteiro MLR et al (2022) Ocular findings in asymptomatic patients with primary antiphospholipid syndrome. Lupus 31(14):1800–1807. https://doi.org/10.1177/09612033221133687

    Article  CAS  PubMed  Google Scholar 

  41. Chin D, Gan NY, Holder GE, Tien M, Agrawal R, Manghani M (2021) Severe retinal vasculitis in systemic lupus erythematosus leading to vision threatening paracentral acute middle maculopathy. Mod Rheumatol Case Rep 5(2):265–271. https://doi.org/10.1080/24725625.2021.1893961

    Article  PubMed  Google Scholar 

  42. Jammal AA, Ogata NG, Daga FB, Abe RY, Costa VP, Medeiros FA (2019) What is the amount of visual field loss associated with disability in glaucoma? Am J Ophthalmol 197:45–52. https://doi.org/10.1016/j.ajo.2018.09.002

    Article  PubMed  Google Scholar 

  43. Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N et al (2010) Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost 8(2):237–242. https://doi.org/10.1111/j.1538-7836.2009.03674.x

    Article  CAS  PubMed  Google Scholar 

  44. Pengo V, Ruffatti A, Legnani C, Testa S, Fierro T, Marongiu F et al (2011) Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood 118(17):4714–4718. https://doi.org/10.1182/blood-2011-03-340232

    Article  CAS  PubMed  Google Scholar 

  45. Radin M, Sciascia S, Erkan D, Pengo V, Tektonidou MG, Ugarte A et al (2019) The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: results from the APS ACTION cohort. Semin Arthritis Rheum 49(3):464–468. https://doi.org/10.1016/j.semarthrit.2019.04.009

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Danieli C. O. Andrade and Leandro C. Zacharias equally contributed.

Authors and Affiliations

  1. Division of Ophthalmology, Faculty of Medicine, Sao Paulo University, Av. Dr. Arnaldo, 455, Cerqueira César, São Paulo, SP, 01246-903, Brazil

    Epitácio D. S. Neto, Taurino S. R. Neto, Alex H. Higashi, Mário Luiz R. Monteiro & Leandro C. Zacharias

  2. Division of Rheumatology, Faculty of Medicine, Sao Paulo University, São Paulo, Brazil

    Flávio Signorelli, Gustavo G. M. Balbi, Eloisa Bonfá & Danieli C. O. Andrade

Authors
  1. Epitácio D. S. Neto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Taurino S. R. Neto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Flávio Signorelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gustavo G. M. Balbi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alex H. Higashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mário Luiz R. Monteiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Eloisa Bonfá
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Danieli C. O. Andrade
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Leandro C. Zacharias
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Epitácio D. S. Neto.

Ethics declarations

Disclosures

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Neto, E.D.S., Neto, T.S.R., Signorelli, F. et al. Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus. Clin Rheumatol 42, 2105–2114 (2023). https://doi.org/10.1007/s10067-023-06613-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-023-06613-9

Keywords

Search

Navigation